Browsed by
Tag: Mark

Artist leaves mark on North Texas with murals across DFW

Artist leaves mark on North Texas with murals across DFW

If you’ve admired a mural or painting in the area, there’s a decent chance you were enjoying the work of Dallas-Fort Worth artist Kyle Wadsworth.

Wadsworth, 49, who was born in Dallas and grew up in Midlothian, has painted all over the Metroplex, from Granbury to Grand Prairie, Fort Worth to Dallas and all points in between. He’s painted the stars of the classic film “Apocalypse Now,” including screen greats Marlon Brando and Robert Duvall, along with NBA star Dwyane Wade, even Spider-Man and musical legend Isaac Hayes.

In Fort Worth, his work can be seen at places such as Wild Acre Brewing Company and Martin House Brewing Company.

“My mother and grandmother were very creative in both painting and theater,” said Wadsworth, who has created murals for 17 years. “When I was trying to solve the riddle of making a living through my art, a Bambi mural in my room, painted by my mother, inspired me to start this career path.”

That path has taken him all over Texas and bordering states. He’s even done some creations in Colorado. Along the way he’s met and honored many famous people with his work.

“I painted several of my favorite murals for Aqib Talib’s (former NFL player) family, a “Scarface” mural in the media room and a War video game mural for their son’s room, as well as several others,” he said.

“The mural for Dr. Delphinium flower shop in Dallas off I-35 is one of my favorites. I also created murals for a pediatric hospital, and the theme for each room was a different board game, Monopoly, Battleship, Hungry Hippo, etc.”

Now he can add to his favorites a gift to Midlothian. His family moved onto 4 acres there in the 1970s and that’s where he attended elementary school.


Read the rest
Algernon Pharmaceuticals Appoints Dr. Mark Swaim MD, PhD to its Medical and Scientific …

Algernon Pharmaceuticals Appoints Dr. Mark Swaim MD, PhD to its Medical and Scientific …

VANCOUVER, British Columbia, Oct. 09, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce that Dr. Mark Swaim, a former practicing physician and researcher has joined the Algernon Medical and Scientific Advisory Board.

Dr. Mark Swaim, MD, PhD graduated from Duke University with honours, where he was an NIH-sponsored Medical Scientist Training Program scholar, and was elected to the Alpha Omega Alpha Honor Medical Society and served as its president. He completed post-graduate training in internal medicine, gastroenterology and hepatology at Duke University Medical Center and post-doctoral research at National Taiwan University in Taipei. Dr. Swaim served on the faculties of Duke University Medical Center, University of Texas MD Anderson Cancer Center and the McGovern Medical School of University of Texas in Houston. He was elected to fellowship in the American College of Physicians. He is editor-in-chief and founder of a small-cap biotech special situations investing website with a global following.

Update on South Korea COVID Trial

Due to a lack of sufficiently ill patients, which is a direct result of a highly-successful government initiated pandemic mitigation strategy, the Company has decided to close the investigator-led South Korea trial. Instead, the Company will remain focused on its Phase 2b/3 multinational Ifenprodil COVID study, which currently has enrolled more than 75% of its target enrollment.

The Company has projected that the multinational Phase 2b/3 study will be completed in November 2020, with a planned data readout before the end of Q4, 2020.

“I am very pleased that Dr. Swaim has accepted our invitation to join our Advisory Board and we look forward to working closely with him,” said Christopher J. Moreau, CEO of Algernon Pharmaceuticals. “We also look forward to reaching

Read the rest
Mark Cross Relaunches Its Men’s Collection And Invests In New Technology

Mark Cross Relaunches Its Men’s Collection And Invests In New Technology

Mark Cross, an American luxury brand established in Boston in 1845, is revisiting its roots and looking to the future in its new men’s collection. While Mark Cross always had men’s pieces, this fall, it fully relaunches the collection with new silhouettes and an exclusive new logo. Pieces and the logo are inspired by the company’s long heritage and archives, but they are thoroughly modern. Mark Cross also partnered with TrueTwins, a technology company that provides a digital passport for every piece. A digital chip is embedded inside the product, which a smartphone can sense. Upon scanning the chip, your phone takes you to the Mark Cross app where you can view the certificate of authenticity, information on the piece’s sustainability, the supply chain, proof of ownership, and warranty. Even if you purchase the piece from someone other than Mark Cross, you can transfer ownership of the piece and add it to your collection. We speak to Sean Mathews, Creative Director, and Ulrik Garde Due, CEO, about the creative inspiration and the business decisions behind the collection. 

What prompted the decision to create a new logo for this collection? 

Mathews: The entire men’s relaunch collection was inspired by pieces from Mark Cross’ 175-year heritage. Mark Cross Signature Logo Jacquard — as an homage to our history, we chose to bring back our classic MC logo using the same exact weaving structure as the original 60’s era jacquard. We scaled up the size proportions, had it woven in Como, Italy using fabrics made from recycled plastic bottles.

What are the pieces from the archive that most influenced the men’s collection? 

Mathews: Specifically a top handle tote bag featuring the MC logo jacquard

Read the rest